ABT-263: A Potent and Orally Bioavailable Bcl-2 Family InhibitorChristin Tse, Steven W. Elmore, Eric F. Johnson et al.|Cancer Research|2008Cited by 2k
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 ProteinsCheol‐Min Park, Steven W. Elmore, Milan Bruncko et al.|Journal of Medicinal Chemistry|2008Cited by 293
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft ModelsAlex R. Shoemaker, Steven W. Elmore, Michael J. Mitten et al.|Clinical Cancer Research|2008Cited by 209